BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,420 | -0.5% | 3,500,000 | 0.0% | 0.01% | -9.1% |
| Q2 2023 | $3,438 | -2.9% | 3,500,000 | 0.0% | 0.01% | -8.3% |
| Q1 2023 | $3,541 | -5.7% | 3,500,000 | 0.0% | 0.01% | -7.7% |
| Q4 2022 | $3,755 | -99.9% | 3,500,000 | 0.0% | 0.01% | -7.1% |
| Q3 2022 | $3,532,000 | -95.0% | 3,500,000 | -16.2% | 0.01% | -94.8% |
| Q2 2022 | $70,578,000 | +1924.6% | 4,175,000 | +19.3% | 0.27% | +2141.7% |
| Q1 2022 | $3,486,000 | -95.3% | 3,500,000 | -16.2% | 0.01% | -95.2% |
| Q4 2021 | $74,141,000 | +1.6% | 4,175,000 | 0.0% | 0.25% | -8.5% |
| Q3 2021 | $72,948,000 | -0.9% | 4,175,000 | 0.0% | 0.27% | +3.4% |
| Q2 2021 | $73,603,000 | +1949.7% | 4,175,000 | +19.3% | 0.26% | +1646.7% |
| Q1 2021 | $3,591,000 | -4.0% | 3,500,000 | 0.0% | 0.02% | -11.8% |
| Q4 2020 | $3,740,000 | +2.0% | 3,500,000 | 0.0% | 0.02% | -19.0% |
| Q3 2020 | $3,668,000 | -14.4% | 3,500,000 | 0.0% | 0.02% | -27.6% |
| Q2 2020 | $4,285,000 | +18.1% | 3,500,000 | 0.0% | 0.03% | -6.5% |
| Q1 2020 | $3,628,000 | -1.7% | 3,500,000 | 0.0% | 0.03% | +24.0% |
| Q4 2019 | $3,690,000 | +6.4% | 3,500,000 | 0.0% | 0.02% | -7.4% |
| Q3 2019 | $3,467,000 | -4.3% | 3,500,000 | 0.0% | 0.03% | -10.0% |
| Q2 2019 | $3,624,000 | +1.3% | 3,500,000 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $3,576,000 | – | 3,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |